Prelude Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.44M | Sell |
21,813
-15,726
| -42% | -$999K | 0.11% | 221 |
|
|
2025
Q4 | $2.39M | Sell |
37,539
-3,938
| -9% | -$245K | 0.18% | 130 |
|
|
2025
Q3 | $2.28M | Buy |
41,477
+5,976
| +17% | +$246K | 0.18% | 131 |
|
|
2025
Q2 | $1.17M | Buy |
35,501
+6,947
| +24% | +$242K | 0.11% | 225 |
|
|
2025
Q1 | $1.15M | Buy |
28,554
+8,348
| +41% | +$384K | 0.12% | 275 |
|
|
2024
Q4 | $950K | Buy |
20,206
+1,315
| +7% | +$68.3K | 0.08% | 395 |
|
|
2024
Q3 | $997K | Buy |
+18,891
| New | +$1.05M | 0.08% | 384 |
|
|
2024
Q2 | – | Sell |
-16,023
| Closed | -$967K | – | 1276 |
|
|
2024
Q1 | $1.12M | Buy |
16,023
+4,237
| +36% | +$328K | 0.08% | 363 |
|
|
2023
Q4 | $984K | Buy |
11,786
+2,086
| +22% | +$75.5K | 0.09% | 306 |
|
|
2023
Q3 | $286K | Buy |
9,700
+631
| +7% | +$21K | 0.03% | 692 |
|
|
2023
Q2 | $296K | Buy |
9,069
+1,767
| +24% | +$65.4K | 0.02% | 651 |
|
|
2023
Q1 | $257K | Buy |
+7,302
| New | +$298K | 0.02% | 724 |
|
|
2020
Q4 | – | Sell |
-18,564
| Closed | -$402K | – | 1463 |
|
|
2020
Q3 | $402K | Buy |
18,564
+7,461
| +67% | +$175K | 0.06% | 483 |
|
|
2020
Q2 | $262K | Buy |
11,103
+8,634
| +350% | +$162K | 0.04% | 656 |
|
|
2020
Q1 | $29K | Sell |
2,469
-5,465
| -69% | -$69.7K | 0.01% | 890 |
|
|
2019
Q4 | $84K | Buy |
+7,934
| New | +$81.5K | 0.01% | 1172 |
|
|
2019
Q1 | – | Sell |
-215
| Closed | -$1K | – | 1843 |
|
|
2018
Q4 | $1K | Buy |
+215
| New | +$1.58K | ﹤0.01% | 1710 |
|
|
2018
Q2 | – | Sell |
-43,743
| Closed | -$315K | – | 1728 |
|
|
2018
Q1 | $315K | Sell |
43,743
-2,595
| -6% | -$22.2K | 0.03% | 574 |
|
|
2017
Q4 | $378K | Buy |
46,338
+10,534
| +29% | +$120K | 0.04% | 486 |
|
|
2017
Q3 | $519K | Buy |
35,804
+11,322
| +46% | +$155K | 0.05% | 365 |
|
|
2017
Q2 | $296K | Sell |
24,482
-387
| -2% | -$5.38K | 0.03% | 462 |
|
|
2017
Q1 | $320K | Buy |
24,869
+19,469
| +361% | +$228K | 0.04% | 420 |
|
|
2016
Q4 | $66K | Buy |
5,400
+2,500
| +86% | +$26.5K | 0.01% | 966 |
|
|
2016
Q3 | $27K | Buy |
2,900
+1,400
| +93% | +$14.6K | ﹤0.01% | 1267 |
|
|
2016
Q2 | $14K | Buy |
+1,500
| New | +$12.3K | ﹤0.01% | 1349 |
|
|
2016
Q1 | – | Sell |
-2,800
| Closed | -$29K | – | 1320 |
|
|
2015
Q4 | $29K | Sell |
2,800
-6,413
| -70% | -$62.9K | 0.01% | 1144 |
|
|
2015
Q3 | $62K | Buy |
9,213
+5,063
| +122% | +$34.6K | 0.01% | 986 |
|
|
2015
Q2 | $28K | Sell |
4,150
-2,100
| -34% | -$13.8K | ﹤0.01% | 1290 |
|
|
2015
Q1 | $42K | Sell |
6,250
-13,000
| -68% | -$97.1K | 0.01% | 1394 |
|
|
2014
Q4 | $154K | Hold |
19,250
| – | – | 0.02% | 807 |
|
|
2014
Q3 | $68K | Buy |
19,250
+6,700
| +53% | +$28.1K | 0.01% | 1269 |
|
|
2014
Q2 | $60K | Buy |
12,550
+10,550
| +528% | +$64.4K | 0.01% | 1299 |
|
|
2014
Q1 | $19K | Sell |
2,000
-3,500
| -64% | -$31.7K | ﹤0.01% | 1699 |
|
|
2013
Q4 | $36K | Buy |
+5,500
| New | +$36.1K | 0.01% | 1172 |
|
Other funds holding CYTK
VPM
VCM
ACA
